ahlam1399
08-23-2016, 01:28 AM
UPDATE 5-Pfizer boosts cancer drug roster with $14 bln Medivation deal
Aug 22 (Reuters) - Pfizer Inc, beating out numerousother bidders, said it agreed to buy U.S. cancer drug companyMedivation Inc for $14 billion in cash, adding itsblockbuster prostate cancer drug Xtandi to the company's growingoncology roster.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=fWaiffJtTcE:qd1LXYu2NxM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=fWaiffJtTcE:qd1LXYu2NxM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=fWaiffJtTcE:qd1LXYu2NxM:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=fWaiffJtTcE:qd1LXYu2NxM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=fWaiffJtTcE:qd1LXYu2NxM:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/fWaiffJtTcE
Aug 22 (Reuters) - Pfizer Inc, beating out numerousother bidders, said it agreed to buy U.S. cancer drug companyMedivation Inc for $14 billion in cash, adding itsblockbuster prostate cancer drug Xtandi to the company's growingoncology roster.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=fWaiffJtTcE:qd1LXYu2NxM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=fWaiffJtTcE:qd1LXYu2NxM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=fWaiffJtTcE:qd1LXYu2NxM:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=fWaiffJtTcE:qd1LXYu2NxM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=fWaiffJtTcE:qd1LXYu2NxM:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/fWaiffJtTcE